KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Clinical trial NCT07353645 · RECRUITING
Trial details
- NCT number
- NCT07353645
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2029-01-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.